Elite Health Systems (EHSI) CEO granted 110,526 stock warrants

Rhea-AI Filing Summary

Elite Health Systems Inc. reported that CEO and 10% owner Jeereddi Prasad Anjaneya received a grant of 110,526 common stock warrants on July 31, 2026, with a $0.95 per-share exercise price and a July 31, 2031 expiration. Following this grant, he holds 3,624,484 common shares directly, 225,716 common shares indirectly through an entity, and the granted warrants.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider jeereddi Prasad Anjaneya

Role CEO

Type	Security	Shares	Price	Value
Grant/Award	Common stock warants	110,526	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock F1	--	--	--

Holdings After Transaction: Common stock warants — 110,526 shares (Direct); Common Stock — 3,624,484 shares (Direct); Common Stock — 225,716 shares (Indirect, See footnote)

Footnotes (1)

1. F1. Shares held by an entity of which the Reporting Person is a managing member and major equity owner

Key Figures

Warrants granted: 110,526 warrants Warrant exercise price: $0.95 per share Warrant expiration: 2031-07-31 +3 more

6 metrics

Warrants granted 110,526 warrants Grant of common stock warrants to CEO on 2026-07-31

Warrant exercise price $0.95 per share conversion_or_exercise_price for granted warrants

Warrant expiration 2031-07-31 Expiration date of the granted common stock warrants

Underlying common shares 110,526 shares Underlying common stock for the granted warrants

Direct common stock holdings 3,624,484 shares Total common shares held directly after the reported transactions

Indirect common stock holdings 225,716 shares Common shares held indirectly through an entity after the transactions

Key Terms

Common stock warants, conversion_or_exercise_price, acquired_disposed_code, indirect, +1 more

5 terms

Common stock warants financial

"security_title is shown as Common stock warants for the derivative grant"

conversion_or_exercise_price financial

"The conversion_or_exercise_price field lists 0.9500 for the warrants"

acquired_disposed_code financial

"acquired_disposed_code is A, indicating an acquisition-type grant"

indirect financial

"ownership_type is indirect for 225,716 common shares held via an entity"

derivative financial

"transaction_type is derivative for the common stock warrants"

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 05:27 PM Accepted by SEC EDGAR 08/04/2026 - 05:26 PM Learn about SEC filing dates

FAQ

What insider transaction did Elite Health Systems (EHSI) report for its CEO?

Elite Health Systems reported that CEO Jeereddi Prasad Anjaneya received a grant of 110,526 common stock warrants on July 31, 2026. These warrants have a $0.95 per-share exercise price and expire on July 31, 2031, representing a new derivative position.

What is the exercise price and expiration date of the new EHSI CEO warrants?

The granted warrants carry a $0.95 exercise price per share and an expiration date of July 31, 2031. Each warrant is exercisable into one share of common stock, based on the underlying 110,526 common shares referenced in the filing.

How many Elite Health Systems (EHSI) common shares does the CEO own after this filing?

After the reported grant, Jeereddi Prasad Anjaneya holds 3,624,484 common shares directly and 225,716 common shares indirectly through an entity where he is a managing member and major equity owner, in addition to the newly granted warrants.

Are any of the EHSI CEO’s shares held indirectly through another entity?

Yes. The filing notes 225,716 common shares held indirectly by an entity of which the reporting person is a managing member and major equity owner. These are reported as indirect ownership, separate from his direct shareholdings.

Were the reported EHSI warrant grants made under a Rule 10b5-1 trading plan?

No. The document-level Rule 10b5-1 checkbox is not marked as affirming a trading plan (aff_10b5_one is false), indicating the warrant grant was not reported as made pursuant to a Rule 10b5-1 plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

jeereddi Prasad Anjaneya

(Last) (First) (Middle)

1131 W. 6TH STREET

SUITE 225

(Street)

ONTARIO CALIFORNIA 91762

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elite Health Systems Inc. [ EHSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								3,624,484	D
Common Stock								225,716	I	See footnote(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common stock warants	$0.95	07/31/2026	07/31/2026	A		110,526		07/31/2026	07/31/2031	Common	110,526	$0	110,526	D

Explanation of Responses:

1. Shares held by an entity of which the Reporting Person is a managing member and major equity owner

	/s/ Prasad A Jeereddi	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)